ShapeShapeauthorShapechevroncrossShapeShapeShapeGrouphamburgerhomeGroupmagnifyShapeShapeShaperssShape

Sponsor message

New 100% online training course from FishVet Group and Benchmark Knowledge Services on The Health and Welfare of Atlantic Salmon

Sea bass vaccine shows promising results

17 September 2018, at 2:00pm

Results of a trial that reduced the impact of a new vaccine that proved efficacious against Listonella anguillarum in sea bass were presented at Aqua2018 by Hipra.

The event, which took place in Montpellier last month, was jointly organized by the European Aquaculture Society (EAS) and the World Aquaculture Society (WAS) and brought together over 3,000 delegates, including producers, veterinarians, scientists and other players in the supply chain.

Erik Díaz and Almudena Sánchez Matamoros beside a poster explaining their sea bass trial
Erik Díaz and Almudena Sánchez Matamoros beside a poster explaining their sea bass trial

From its stand, Hipra demonstrated its Icthiovac range of inactivated vaccines, designed for gilthead sea bream, sea bass, trout and turbot.

During the event, Hipra presented the promising results from a trial undertaken by Almudena Sánchez Matamoros and Erik Díaz. This looked at the efficacy of Icthiovac VR/PD against Listonella anguillarum in sea bass under adverse conditions of low temperature and a short post-vaccination period.

Learn more
 

The Health and Welfare of Atlantic Salmon course

It is vital that fish farm operatives who are responsible for farmed fish are trained in their health and welfare. This will help to ensure that fish are free from disease and suffering whilst at the same time promote good productivity and comply with legislation.

Find out more